Global Hydromorphone Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Hydromorphone will have significant change from previous year. By the most conservative estimates of global Hydromorphone market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Hydromorphone market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Hydromorphone market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Hydromorphone, covering the supply chain analysis, impact assessment to the Hydromorphone market size growth rate in several scenarios, and the measures to be undertaken by Hydromorphone companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Oral
Injection
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drug Store
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Purdue Pharma
Apotex
Akorn
Pfizer
Watson Laboratories
Barr Pharmaceuticals
KV Pharmaceutical
Mallinckrodt
Lannett
Teva Pharmaceuticals
Mylan
Fresenius
Novartis
Mundipharma
Stada Arzneimittel
Johnson and Johnson
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Hydromorphone consumption (value & volume) by key regions/countries, type and access channel, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Hydromorphone market by identifying its various subsegments.
Focuses on the key global Hydromorphone manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hydromorphone with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hydromorphone submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Hydromorphone?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Hydromorphone Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hydromorphone Consumption 2015-2025
2.1.2 Hydromorphone Consumption CAGR by Region
2.2 Hydromorphone Segment by Type
2.2.1 Oral
2.2.2 Injection
2.3 Hydromorphone Consumption by Type
2.3.1 Global Hydromorphone Consumption Market Share by Type (2015-2020)
2.3.2 Global Hydromorphone Revenue and Market Share by Type (2015-2020)
2.3.3 Global Hydromorphone Sale Price by Type (2015-2020)
2.4 Hydromorphone Segment by Access Channel
2.4.1 Hospital
2.4.2 Drug Store
2.5 Hydromorphone Consumption by Access Channel
2.5.1 Global Hydromorphone Consumption Market Share by Type (2015-2020)
2.5.2 Global Hydromorphone Value and Market Share by Type (2015-2020)
2.5.3 Global Hydromorphone Sale Price by Type (2015-2020)
3 Global Hydromorphone by Company
3.1 Global Hydromorphone Sales Market Share by Company
3.1.1 Global Hydromorphone Sales by Company (2018-2020)
3.1.2 Global Hydromorphone Sales Market Share by Company (2018-2020)
3.2 Global Hydromorphone Revenue Market Share by Company
3.2.1 Global Hydromorphone Revenue by Company (2018-2020)
3.2.2 Global Hydromorphone Revenue Market Share by Company (2018-2020)
3.3 Global Hydromorphone Sale Price by Company
3.4 Global Hydromorphone Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Hydromorphone Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Hydromorphone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Hydromorphone by Regions
4.1 Hydromorphone by Regions
4.2 Americas Hydromorphone Consumption Growth
4.3 APAC Hydromorphone Consumption Growth
4.4 Europe Hydromorphone Consumption Growth
4.5 Middle East & Africa Hydromorphone Consumption Growth
5 Americas
5.1 Americas Hydromorphone Consumption by Countries
5.1.1 Americas Hydromorphone Consumption by Countries (2015-2020)
5.1.2 Americas Hydromorphone Value by Countries (2015-2020)
5.2 Americas Hydromorphone Consumption by Type
5.3 Americas Hydromorphone Consumption by Access Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Hydromorphone Consumption by Regions
6.1.1 APAC Hydromorphone Consumption by Regions (2015-2020)
6.1.2 APAC Hydromorphone Value by Regions (2015-2020)
6.2 APAC Hydromorphone Consumption by Type
6.3 APAC Hydromorphone Consumption by Access Channel
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Hydromorphone by Countries
7.1.1 Europe Hydromorphone Consumption by Countries (2015-2020)
7.1.2 Europe Hydromorphone Value by Countries (2015-2020)
7.2 Europe Hydromorphone Consumption by Type
7.3 Europe Hydromorphone Consumption by Access Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Hydromorphone by Countries
8.1.1 Middle East & Africa Hydromorphone Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Hydromorphone Value by Countries (2015-2020)
8.2 Middle East & Africa Hydromorphone Consumption by Type
8.3 Middle East & Africa Hydromorphone Consumption by Access Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Hydromorphone Distributors
10.3 Hydromorphone Customer
11 Global Hydromorphone Market Forecast
11.1 Global Hydromorphone Consumption Forecast (2021-2025)
11.2 Global Hydromorphone Forecast by Regions
11.2.1 Global Hydromorphone Forecast by Regions (2021-2025)
11.2.2 Global Hydromorphone Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Hydromorphone Forecast by Type
11.8 Global Hydromorphone Forecast by Access Channel
12 Key Players Analysis
12.1 Purdue Pharma
12.1.1 Company Information
12.1.2 Hydromorphone Product Offered
12.1.3 Purdue Pharma Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Purdue Pharma Latest Developments
12.2 Apotex
12.2.1 Company Information
12.2.2 Hydromorphone Product Offered
12.2.3 Apotex Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Apotex Latest Developments
12.3 Akorn
12.3.1 Company Information
12.3.2 Hydromorphone Product Offered
12.3.3 Akorn Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Akorn Latest Developments
12.4 Pfizer
12.4.1 Company Information
12.4.2 Hydromorphone Product Offered
12.4.3 Pfizer Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Watson Laboratories
12.5.1 Company Information
12.5.2 Hydromorphone Product Offered
12.5.3 Watson Laboratories Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Watson Laboratories Latest Developments
12.6 Barr Pharmaceuticals
12.6.1 Company Information
12.6.2 Hydromorphone Product Offered
12.6.3 Barr Pharmaceuticals Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Barr Pharmaceuticals Latest Developments
12.7 KV Pharmaceutical
12.7.1 Company Information
12.7.2 Hydromorphone Product Offered
12.7.3 KV Pharmaceutical Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 KV Pharmaceutical Latest Developments
12.8 Mallinckrodt
12.8.1 Company Information
12.8.2 Hydromorphone Product Offered
12.8.3 Mallinckrodt Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Mallinckrodt Latest Developments
12.9 Lannett
12.9.1 Company Information
12.9.2 Hydromorphone Product Offered
12.9.3 Lannett Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Lannett Latest Developments
12.10 Teva Pharmaceuticals
12.10.1 Company Information
12.10.2 Hydromorphone Product Offered
12.10.3 Teva Pharmaceuticals Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Teva Pharmaceuticals Latest Developments
12.11 Mylan
12.11.1 Company Information
12.11.2 Hydromorphone Product Offered
12.11.3 Mylan Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Mylan Latest Developments
12.12 Fresenius
12.12.1 Company Information
12.12.2 Hydromorphone Product Offered
12.12.3 Fresenius Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Fresenius Latest Developments
12.13 Novartis
12.13.1 Company Information
12.13.2 Hydromorphone Product Offered
12.13.3 Novartis Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Novartis Latest Developments
12.14 Mundipharma
12.14.1 Company Information
12.14.2 Hydromorphone Product Offered
12.14.3 Mundipharma Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Mundipharma Latest Developments
12.15 Stada Arzneimittel
12.15.1 Company Information
12.15.2 Hydromorphone Product Offered
12.15.3 Stada Arzneimittel Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Stada Arzneimittel Latest Developments
12.16 Johnson and Johnson
12.16.1 Company Information
12.16.2 Hydromorphone Product Offered
12.16.3 Johnson and Johnson Hydromorphone Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Johnson and Johnson Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Hydromorphone Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Hydromorphone Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Hydromorphone Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Oral
Table 7. Major Players of Injection
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Hydromorphone Consumption Market Share by Type (2015-2020)
Table 10. Global Hydromorphone Revenue by Type (2015-2020) ($ million)
Table 11. Global Hydromorphone Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Hydromorphone Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Access Channel (2015-2020)
Table 14. Global Hydromorphone Consumption Market Share by Access Channel (2015-2020)
Table 15. Global Hydromorphone Value by Access Channel (2015-2020)
Table 16. Global Hydromorphone Value Market Share by Access Channel (2015-2020)
Table 17. Global Hydromorphone Sale Price by Access Channel (2015-2020)
Table 18. Global Hydromorphone Sales by Company (2017-2019) (K Units)
Table 19. Global Hydromorphone Sales Market Share by Company (2017-2019)
Table 20. Global Hydromorphone Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Hydromorphone Revenue Market Share by Company (2017-2019)
Table 22. Global Hydromorphone Sale Price by Company (2017-2019)
Table 23. Global Hydromorphone Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Hydromorphone Products Offered
Table 25. Hydromorphone Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Hydromorphone Consumption by Regions 2015-2020 (K Units)
Table 27. Global Hydromorphone Consumption Market Share by Regions 2015-2020
Table 28. Global Hydromorphone Value by Regions 2015-2020 ($ Millions)
Table 29. Global Hydromorphone Value Market Share by Regions 2015-2020
Table 30. Americas Hydromorphone Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Hydromorphone Consumption Market Share by Countries (2015-2020)
Table 32. Americas Hydromorphone Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Hydromorphone Value Market Share by Countries (2015-2020)
Table 34. Americas Hydromorphone Consumption by Type (2015-2020) (K Units)
Table 35. Americas Hydromorphone Consumption Market Share by Type (2015-2020)
Table 36. Americas Hydromorphone Consumption by Access Channel (2015-2020) (K Units)
Table 37. Americas Hydromorphone Consumption Market Share by Access Channel (2015-2020)
Table 38. APAC Hydromorphone Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Hydromorphone Consumption Market Share by Countries (2015-2020)
Table 40. APAC Hydromorphone Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Hydromorphone Value Market Share by Regions (2015-2020)
Table 42. APAC Hydromorphone Consumption by Type (2015-2020) (K Units)
Table 43. APAC Hydromorphone Consumption Market Share by Type (2015-2020)
Table 44. APAC Hydromorphone Consumption by Access Channel (2015-2020) (K Units)
Table 45. APAC Hydromorphone Consumption Market Share by Access Channel (2015-2020)
Table 46. Europe Hydromorphone Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Hydromorphone Consumption Market Share by Countries (2015-2020)
Table 48. Europe Hydromorphone Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Hydromorphone Value Market Share by Countries (2015-2020)
Table 50. Europe Hydromorphone Consumption by Type (2015-2020) (K Units)
Table 51. Europe Hydromorphone Consumption Market Share by Type (2015-2020)
Table 52. Europe Hydromorphone Consumption by Access Channel (2015-2020) (K Units)
Table 53. Europe Hydromorphone Consumption Market Share by Access Channel (2015-2020)
Table 54. Middle East & Africa Hydromorphone Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Hydromorphone Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Hydromorphone Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Hydromorphone Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Hydromorphone Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Hydromorphone Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Hydromorphone Consumption by Access Channel (2015-2020) (K Units)
Table 61. Middle East & Africa Hydromorphone Consumption Market Share by Access Channel (2015-2020)
Table 62. Hydromorphone Distributors List
Table 63. Hydromorphone Customer List
Table 64. Global Hydromorphone Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Hydromorphone Consumption Market Forecast by Regions
Table 66. Global Hydromorphone Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Hydromorphone Value Market Share Forecast by Regions
Table 68. Global Hydromorphone Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Hydromorphone Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Hydromorphone Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Hydromorphone Value Market Share Forecast by Type (2021-2025)
Table 72. Global Hydromorphone Consumption Forecast by Access Channel (2021-2025) (K Units)
Table 73. Global Hydromorphone Consumption Market Share Forecast by Access Channel (2021-2025)
Table 74. Global Hydromorphone Value Forecast by Access Channel (2021-2025) ($ Millions)
Table 75. Global Hydromorphone Value Market Share Forecast by Access Channel (2021-2025)
Table 76. Purdue Pharma Product Offered
Table 77. Purdue Pharma Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. Purdue Pharma Main Business
Table 79. Purdue Pharma Latest Developments
Table 80. Purdue Pharma Basic Information, Company Total Revenue (in $ million), Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 81. Apotex Product Offered
Table 82. Apotex Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Apotex Main Business
Table 84. Apotex Latest Developments
Table 85. Apotex Basic Information, Company Total Revenue (in $ million), Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 86. Akorn Product Offered
Table 87. Akorn Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Akorn Main Business
Table 89. Akorn Latest Developments
Table 90. Akorn Basic Information, Company Total Revenue (in $ million), Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 91. Pfizer Product Offered
Table 92. Pfizer Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Pfizer Main Business
Table 94. Pfizer Latest Developments
Table 95. Pfizer Basic Information, Company Total Revenue (in $ million), Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 96. Watson Laboratories Product Offered
Table 97. Watson Laboratories Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Watson Laboratories Main Business
Table 99. Watson Laboratories Latest Developments
Table 100. Watson Laboratories Basic Information, Company Total Revenue (in $ million), Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 101. Barr Pharmaceuticals Product Offered
Table 102. Barr Pharmaceuticals Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. Barr Pharmaceuticals Main Business
Table 104. Barr Pharmaceuticals Latest Developments
Table 105. Barr Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 106. KV Pharmaceutical Product Offered
Table 107. KV Pharmaceutical Basic Information, Company Total Revenue (in $ million), Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 108. KV Pharmaceutical Main Business
Table 109. KV Pharmaceutical Latest Developments
Table 110. KV Pharmaceutical Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Mallinckrodt Product Offered
Table 112. Mallinckrodt Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Mallinckrodt Main Business
Table 114. Mallinckrodt Latest Developments
Table 115. Mallinckrodt Basic Information, Company Total Revenue (in $ million), Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 116. Lannett Product Offered
Table 117. Lannett Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. Lannett Main Business
Table 119. Lannett Latest Developments
Table 120. Lannett Basic Information, Company Total Revenue (in $ million), Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 121. Teva Pharmaceuticals Product Offered
Table 122. Teva Pharmaceuticals Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. Teva Pharmaceuticals Main Business
Table 124. Teva Pharmaceuticals Latest Developments
Table 125. Teva Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Hydromorphone Manufacturing Base, Sales Area and Its Competitors
Table 126. Mylan Product Offered
Table 127. Mylan Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 128. Mylan Main Business
Table 129. Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Mylan Latest Developments
Table 131. Fresenius Product Offered
Table 132. Fresenius Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 133. Fresenius Main Business
Table 134. Fresenius Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Fresenius Latest Developments
Table 136. Novartis Product Offered
Table 137. Novartis Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 138. Novartis Main Business
Table 139. Novartis Latest Developments
Table 140. Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 141. Mundipharma Product Offered
Table 142. Mundipharma Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 143. Mundipharma Main Business
Table 144. Mundipharma Latest Developments
Table 145. Mundipharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 146. Stada Arzneimittel Product Offered
Table 147. Stada Arzneimittel Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 148. Stada Arzneimittel Main Business
Table 149. Stada Arzneimittel Latest Developments
Table 150. Stada Arzneimittel Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 151. Johnson and Johnson Product Offered
Table 152. Johnson and Johnson Hydromorphone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 153. Johnson and Johnson Main Business
Table 154. Johnson and Johnson Latest Developments
Table 155. Johnson and Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Hydromorphone
Figure 2. Hydromorphone Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Hydromorphone Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Hydromorphone Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Oral
Figure 7. Product Picture of Injection
Figure 8. Global Hydromorphone Consumption Market Share by Type (2015-2020)
Figure 9. Global Hydromorphone Value Market Share by Type (2015-2020)
Figure 10. Hydromorphone Consumed in Hospital
Figure 11. Global Hydromorphone Market: Hospital (2015-2020) (K Units)
Figure 12. Global Hydromorphone Market: Hospital (2015-2020) ($ Millions)
Figure 13. Hydromorphone Consumed in Drug Store
Figure 14. Global Hydromorphone Market: Drug Store (2015-2020) (K Units)
Figure 15. Global Hydromorphone Market: Drug Store (2015-2020) ($ Millions)
Figure 16. Global Hydromorphone Consumption Market Share by Access Channel (2015-2020)
Figure 17. Global Hydromorphone Value Market Share by Access Channel (2015-2020)
Figure 18. Global Hydromorphone Sales Market Share by Company in 2017
Figure 19. Global Hydromorphone Sales Market Share by Company in 2019
Figure 20. Global Hydromorphone Revenue Market Share by Company in 2017
Figure 21. Global Hydromorphone Revenue Market Share by Company in 2019
Figure 22. Global Hydromorphone Sale Price by Company in 2019
Figure 23. Global Hydromorphone Consumption Market Share by Regions 2015-2020
Figure 24. Global Hydromorphone Value Market Share by Regions 2015-2020
Figure 25. Americas Hydromorphone Consumption 2015-2020 (K Units)
Figure 26. Americas Hydromorphone Value 2015-2020 ($ Millions)
Figure 27. APAC Hydromorphone Consumption 2015-2020 (K Units)
Figure 28. APAC Hydromorphone Value 2015-2020 ($ Millions)
Figure 29. Europe Hydromorphone Consumption 2015-2020 (K Units)
Figure 30. Europe Hydromorphone Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Hydromorphone Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa Hydromorphone Value 2015-2020 ($ Millions)
Figure 33. Americas Hydromorphone Consumption Market Share by Countries in 2019
Figure 34. Americas Hydromorphone Value Market Share by Countries in 2019
Figure 35. Americas Hydromorphone Consumption Market Share by Type in 2019
Figure 36. Americas Hydromorphone Consumption Market Share by Access Channel in 2019
Figure 37. United States Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 38. United States Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 40. Canada Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Hydromorphone Consumption Market Share by Countries in 2019
Figure 44. APAC Hydromorphone Value Market Share by Regions in 2019
Figure 45. APAC Hydromorphone Consumption Market Share by Type in 2019
Figure 46. APAC Hydromorphone Consumption Market Share by Access Channel in 2019
Figure 47. China Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 48. China Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 50. Japan Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 52. Korea Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 55. India Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 56. India Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 58. Australia Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Hydromorphone Consumption Market Share by Countries in 2019
Figure 60. Europe Hydromorphone Value Market Share by Countries in 2019
Figure 61. Europe Hydromorphone Consumption Market Share by Type in 2019
Figure 62. Europe Hydromorphone Consumption Market Share by Access Channel in 2019
Figure 63. Germany Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 64. Germany Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 65. France Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 66. France Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 67. UK Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 68. UK Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 70. Italy Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 72. Russia Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Hydromorphone Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Hydromorphone Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Hydromorphone Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Hydromorphone Consumption Market Share by Access Channel in 2019
Figure 77. Egypt Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 82. Israel Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Hydromorphone Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries Hydromorphone Value Growth 2015-2020 ($ Millions)
Figure 87. Global Hydromorphone Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global Hydromorphone Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Hydromorphone Consumption 2021-2025 (K Units)
Figure 90. Americas Hydromorphone Value 2021-2025 ($ Millions)
Figure 91. APAC Hydromorphone Consumption 2021-2025 (K Units)
Figure 92. APAC Hydromorphone Value 2021-2025 ($ Millions)
Figure 93. Europe Hydromorphone Consumption 2021-2025 (K Units)
Figure 94. Europe Hydromorphone Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Hydromorphone Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa Hydromorphone Value 2021-2025 ($ Millions)
Figure 97. United States Hydromorphone Consumption 2021-2025 (K Units)
Figure 98. United States Hydromorphone Value 2021-2025 ($ Millions)
Figure 99. Canada Hydromorphone Consumption 2021-2025 (K Units)
Figure 100. Canada Hydromorphone Value 2021-2025 ($ Millions)
Figure 101. Mexico Hydromorphone Consumption 2021-2025 (K Units)
Figure 102. Mexico Hydromorphone Value 2021-2025 ($ Millions)
Figure 103. Brazil Hydromorphone Consumption 2021-2025 (K Units)
Figure 104. Brazil Hydromorphone Value 2021-2025 ($ Millions)
Figure 105. China Hydromorphone Consumption 2021-2025 (K Units)
Figure 106. China Hydromorphone Value 2021-2025 ($ Millions)
Figure 107. Japan Hydromorphone Consumption 2021-2025 (K Units)
Figure 108. Japan Hydromorphone Value 2021-2025 ($ Millions)
Figure 109. Korea Hydromorphone Consumption 2021-2025 (K Units)
Figure 110. Korea Hydromorphone Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Hydromorphone Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia Hydromorphone Value 2021-2025 ($ Millions)
Figure 113. India Hydromorphone Consumption 2021-2025 (K Units)
Figure 114. India Hydromorphone Value 2021-2025 ($ Millions)
Figure 115. Australia Hydromorphone Consumption 2021-2025 (K Units)
Figure 116. Australia Hydromorphone Value 2021-2025 ($ Millions)
Figure 117. Germany Hydromorphone Consumption 2021-2025 (K Units)
Figure 118. Germany Hydromorphone Value 2021-2025 ($ Millions)
Figure 119. France Hydromorphone Consumption 2021-2025 (K Units)
Figure 120. France Hydromorphone Value 2021-2025 ($ Millions)
Figure 121. UK Hydromorphone Consumption 2021-2025 (K Units)
Figure 122. UK Hydromorphone Value 2021-2025 ($ Millions)
Figure 123. Italy Hydromorphone Consumption 2021-2025 (K Units)
Figure 124. Italy Hydromorphone Value 2021-2025 ($ Millions)
Figure 125. Russia Hydromorphone Consumption 2021-2025 (K Units)
Figure 126. Russia Hydromorphone Value 2021-2025 ($ Millions)
Figure 127. Spain Hydromorphone Consumption 2021-2025 (K Units)
Figure 128. Spain Hydromorphone Value 2021-2025 ($ Millions)
Figure 129. Egypt Hydromorphone Consumption 2021-2025 (K Units)
Figure 130. Egypt Hydromorphone Value 2021-2025 ($ Millions)
Figure 131. South Africa Hydromorphone Consumption 2021-2025 (K Units)
Figure 132. South Africa Hydromorphone Value 2021-2025 ($ Millions)
Figure 133. Israel Hydromorphone Consumption 2021-2025 (K Units)
Figure 134. Israel Hydromorphone Value 2021-2025 ($ Millions)
Figure 135. Turkey Hydromorphone Consumption 2021-2025 (K Units)
Figure 136. Turkey Hydromorphone Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Hydromorphone Consumption 2021-2025 (K Units)
Figure 138. GCC Countries Hydromorphone Value 2021-2025 ($ Millions)
Figure 139. Purdue Pharma Hydromorphone Market Share (2018-2020)
Figure 140. Apotex Hydromorphone Market Share (2018-2020)
Figure 141. Akorn Hydromorphone Market Share (2018-2020)
Figure 142. Pfizer Hydromorphone Market Share (2018-2020)
Figure 143. Watson Laboratories Hydromorphone Market Share (2018-2020)
Figure 144. Barr Pharmaceuticals Hydromorphone Market Share (2018-2020)
Figure 145. KV Pharmaceutical Hydromorphone Market Share (2018-2020)
Figure 146. Mallinckrodt Hydromorphone Market Share (2018-2020)
Figure 147. Lannett Hydromorphone Market Share (2018-2020)
Figure 148. Teva Pharmaceuticals Hydromorphone Market Share (2018-2020)
Figure 149. Mylan Hydromorphone Market Share (2018-2020)
Figure 150. Fresenius Hydromorphone Market Share (2018-2020)
Figure 151. Novartis Hydromorphone Market Share (2018-2020)
Figure 152. Mundipharma Hydromorphone Market Share (2018-2020)
Figure 153. Stada Arzneimittel Hydromorphone Market Share (2018-2020)
Figure 154. Johnson and Johnson Hydromorphone Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets